Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Canadian Biopharma Stock Climbs On Distribution Deal

Published 2019-10-31, 11:30 a/m
Updated 2023-07-09, 06:31 a/m

An oversees distribution agreement powered a Canadian biopharma stock sharply higher Wednesday.

Tetra Bio Pharma Inc (TSXV:TBP), a Canadian biopharma stock, surged 27% to $0.235 on Wednesday after its wholly-owned subsidiary announced that it has signed a binding term sheet with Azevedos Indústria Farmacêutica, S.A. for the distribution of Awaye in Portugal, Tunisia, and Mozambique. Awaye is a topical product to help relieve local pain in patients with both acute and chronic pain.

As well, shares of Almaden Minerals Ltd (TSX:AMM) slipped 12% to $0.73 as the resource junior said it was notified by SEMARNAT, Mexico’s environmental authority, that the permitting process for the Ixtaca project has been suspended pending resolution of the mineral title lawsuit reported by the company on Sept. 10 and April 15, 2019.

North American Construction Group Ltd (TSX:NOA), meanwhile, reported third-quarter revenue that rose 96% to $166.3 million, while adjusted net earnings for the quarter was $10.5 million, $5.9 million higher than during the same period last year. Both revenue and earnings surpassed the analyst consensus estimates. North American Construction Group stock moved up 8% to $15.73 following the announcement.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.